Valuation: MINDESTA

Market Cap 3.58M 3.13M 2.9M 2.66M 5.03M 345M 5.12M 34.53M 13.56M 169M 13.45M 13.15M 582M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 3.58M 3.13M 2.9M 2.66M 5.03M 345M 5.12M 34.56M 13.58M 169M 13.46M 13.17M 582M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 2014-09-08
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%-1.27%+0.95%+5.66% 50.35B
-2.85%-6.25%+366.61%+572.09% 39.21B
+1.98%+4.82%+13.71%+61.68% 34.6B
+1.78%+0.73%+32.68%-4.80% 34.52B
+0.06%+1.56%+4.41%+27.42% 27.05B
-3.27%-5.67% - - 16.68B
+1.64%+0.45%+70.86%+121.18% 15.11B
+0.29%+1.02%+14.95%+17.80% 13.85B
-1.21%+0.73%+18.02%-30.96% 13.18B
Average -0.29%+0.12%+65.27%+96.26% 27.17B
Weighted average by Cap. -0.31%+0.41%+77.50%+118.91%

Financials

2024 2025
Net sales - -
Net income -250K -219K -202K -186K -351K -24.11M -357K -2.41M -948K -11.77M -940K -919K -40.65M -156K -136K -126K -116K -219K -15.02M -223K -1.5M -590K -7.34M -585K -573K -25.33M
Net Debt 16.82K 14.7K 13.6K 12.48K 23.61K 1.62M 24.02K 162K 63.7K 791K 63.16K 61.77K 2.73M 3.46K 3.02K 2.79K 2.56K 4.85K 333K 4.93K 33.31K 13.08K 163K 12.97K 12.69K 561K
Logo MINDESTA
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-